February 25, 2017 9:46 AM ET

Pharmaceuticals

Company Overview of Pique Therapeutics, Inc.

Key Executives for Pique Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Christopher S. Meldrum 5 RelationshipsPresident and Member of the Board of Directors--
Eckhard R. Podack M.D., Ph.D.5 RelationshipsChief Scientific Officer and Director--

Pique Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Christopher S. Meldrum 5 RelationshipsArcato Laboratories, Inc.--
Eckhard R. Podack M.D., Ph.D. 5 RelationshipsPique Therapeutics, Inc.--
Keith E. Dionne Ph.D. 3 RelationshipsThird Rock Ventures, LLC--
Jay Brennan J.D., MBA 6 RelationshipsPique Therapeutics, Inc.--
View All Board Members

Pique Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
345.6K
Bonus
402.6K
Total Short Term Compensation
491.3K
Total Value of Options
15.0M
Compensation as of Fiscal Year
Pique Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sumitomo Dainippon Pharma Co., Ltd. Announces Executive Changes
February 24, 2017 3:00 PM ET
Daiichi Sankyo Company, Limited Appoints New Group Corporate Officers
February 24, 2017 7:02 AM ET
Jun Hishida to Retire as Executive Vice President of Kitasato Daiichi Sankyo Vaccine Co., Ltd, Effective March 31, 2017
February 24, 2017 7:02 AM ET
CCM Duopharma Biotech Berhad Announces the Resignation of Byung-Geon Rhee as Independent and Non Executive Director, Effective February 25, 2017
February 24, 2017 4:35 AM ET
RespireRx Pharmaceuticals Inc. Announces Management Changes
February 23, 2017 10:28 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pique Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.